The divergence between active asset-manager accumulation and quant-fund exit is a high-conviction structural signal: active managers are betting on fundamental execution of the OCS commercial rollout, while quants are cutting risk regardless of thesis. Traders should monitor the upcoming quarterly earnings for evidence of OCS case-volume acceleration to validate the activist/active thesis before initiating a long. A break above recent technical resistance on heavy volume would confirm the institutional buying trend.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 12 $72.91entry
- T+1 · 5mo ago +3.52%α +1.76% · $75.48
- T+5 · 5mo ago +8.06%α +7.39% · $78.79
- T+20 · 4mo ago −2.30%α −4.08% · $71.23
- T+60 · 2mo ago +21.07%α +17.80% · $88.27
How similar events traded
Executive Summary
TransMedics attracted heavy net institutional accumulation in Q3 2024, with 25 buyers adding $121.7M in new exposure against 11 sellers reducing $86.5M. Buying was concentrated among major active asset managers (FIL, Franklin Resources, Farallon, Ameriprise) all doubling or more-than-doubling positions, while sellers were primarily quant funds exiting entirely (Citadel, D.E. Shaw, Bridgewater). The active-buyer versus quant-seller split suggests fundamental conviction on the OCS platform thesis clashing with systematic risk-off positioning in high-growth medtech.
Key Financial Metrics
Institutional Positions
Net institutional flow: $35.2M
▲ Buyers (25)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fil (Fidelity) | DOUBLED | +107.4% | $122.7M | $65.9M |
| Franklin Resources | DOUBLED | +124% | $36.3M | $18.1M |
| Norges Bank | ADD | +32.7% | $56.2M | $15.6M |
| Ameriprise Financial | DOUBLED | +112.3% | $19.2M | $10.6M |
| Farallon Capital Management | DOUBLED | +2100% | $6.9M | $6.6M |
▼ Sellers (11)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| D.E. Shaw | EXIT | -100% | $31.7M | -$31.7M |
| Voloridge Investment Management | TRIM | -28.4% | $66.3M | -$16.8M |
| Canada Pension Plan Investment Board | TRIM | -74.6% | $16.1M | -$11.8M |
| Citadel | EXIT | -100% | $11.8M | -$11.8M |
| Prudential Financial | NEAR_EXIT | -95.2% | $9.6M | -$9.1M |
Key Facts
- Net aggregate institutional inflow of $35.2M (25 buyers at +$121.7M vs 11 sellers at -$86.5M)
- FIL (Fidelity) more than doubled its stake to $122.7M, the largest single buyer at +$65.9M
- Franklin Resources doubled to $36.3M (+$18.1M) and Ameriprise doubled to $19.2M (+$10.6M)
- D.E. Shaw fully exited a $31.7M position; Citadel fully exited an $11.8M position
- Farallon Capital Management boosted a near-mid size position by 21x to $6.9M
- Selling was dominated by quant/multi-manager funds (D.E. Shaw, Citadel, Bridgewater, Voloridge), pattern consistent with systematic risk reduction, not fundamental bearishness
Financial Impact
Net institutional inflow of approximately $35.2M, with $147.8M of concentrated active-manager additions offsetting $86.5M of quant/MM fund reductions
Risk Factors
- Active-manager accumulation occurred in Q3 2024; 13F data filed with a 45-day lag may not reflect current positioning
- D.E. Shaw and Citadel full exits indicate sophisticated multi-manager funds see risk factors the active buyers may be underestimating
- Potential post-de-SPAC dilution overhang or pending share issuance
- Sector rotation out of high-growth medtech could overwhelm active-manager demand
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-TMDX-2024-Q3 |
Track record
9 reports on TMDX
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $90.95 settles Nov 17
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $88.24 to $91.38 ▲ +3.56% +0.96% vs SPY
- Nov 5, 202611d ago Press Release Bullish 6/10 No price data
- Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Viewing Entry $72.91 to $78.79 ▲ +8.06% +7.39% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 ▼ −0.50% −0.94% vs SPY
- Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 ▲ +1.64% −2.86% vs SPY
- Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 ▼ −8.32% −7.11% vs SPY
- Feb 27, 202637w ago 8-K Neutral 4/10 Entry $145.26 to $129.61 ▼ −10.77% −8.79% vs SPY
- Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 ▲ +11.99% +13.09% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers